© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About N/A of PBLA shares are held by financial institutions. BANK OF AMERICA CORP /DE/ is the top corporate investor, holding 0 shares valued at -. A 0% stake in Panbela Therapeutics, Inc. is owned by the company. WELLS FARGO & COMPANY/MN owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the PBLA insiders holding of 0% of the stake in company, GOLDMAN SACHS GROUP INC, 10 percent owner, holds the largest shares of 397.95K. SCHEMEL DONALD ROBERT, director, is the second largest PBLA insider with ownership of 300K shares. CULLEN MICHAEL T., director, stands third with possession of 247K shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own PBLA shares is 0, representing N/A of the company's common stock.
BANK OF AMERICA CORP /DE/, in the last quarter, reduced its stake in PBLA by -100% restricting it's holding to 0 shares of worth nearly -. WELLS FARGO & COMPANY/MN also lessened -100% of the PBLA shares from its portfolio, reducing its holding to 0 shares of worth -. VANGUARD GROUP INC also shunned PBLA shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, N/A increased its stake in PBLA by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of PBLA to its portfolio, raising its holding to - shares of worth -. N/A also increased its PBLA shares holding by N/A which brought its holding to - shares worth -.
The insider with the most stakes in PBLA is GOLDMAN SACHS GROUP INC , 10 percent owner at the company. Additionally, PBLA stock is highly held by director Schemel Donald Robert and director Cullen Michael T. among others.
Company executives, directors, and other insiders own 0% percent of Panbela Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which PBLA insiders have sold stock, totaling 0 shares. Insiders that have sold shares include GOLDMAN SACHS GROUP INC.
There have been 1 transaction(s) during the past 6-months in which Panbela Therapeutics, Inc. insiders have bought stock, totalling 0 shares
Around 0 Panbela Therapeutics, Inc. shares are held by insiders, which represents about 0% of PBLA stock.
PBLA 10 percent owner, GOLDMAN SACHS GROUP INC holds the largest portfolio of the company's shares. PBLA shares owned by GOLDMAN total nearly 397.95 thousand.
BANK OF AMERICA CORP /DE/ is the largest institutional owner in PBLA which holds 0 shares worth - or 0% of the total PBLA shares outstanding followed by WELLS FARGO & COMPANY/MN with ownership of 0 shares representing 0% of the PBLA ownership. VANGUARD GROUP INC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the PBLA is concerned, it is a stock which is not optionable.
Number of PBLA shares short is 106.97K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 4.85M shares of PBLA are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, PBLA has 4.85M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for PBLA is 0.07.